Coronado Stocked to Go it Alone, Says CEO
Dr. Bobby Sandage, CEO of Coronado Biosciences, says the company has more than enough cash to develop its two key drugs without a big pharma partner.
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
